Ethofylline & Theophylline Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 77 mg+23mg, 169mg+51mg
Reference Brands: Deriphyllin (India), Theodryl (india)
Category:
Respiratory Disorder
Etofylline+Theophylline is used in the treatment and prevention of chronic obstructive pulmonary disease. Etofylline + Theophylline is a combination of two bronchodilators: Etofylline and Theophylline. They work by relaxing the muscles in the airways and widen the airways. This makes breathing easier.
Ethofylline & Theophylline Tablet is available in Tablets
and strengths such as 77 mg+23mg, 169mg+51mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ethofylline & Theophylline Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ethofylline & Theophylline Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Etophylline and Theophylline is a combination bronchodilator medication widely used in the management of respiratory conditions such as chronic obstructive pulmonary disease (COPD) and bronchial asthma. This formulation combines two xanthine derivatives that work synergistically to relax the smooth muscles of the airways, leading to bronchodilation and improved airflow to the lungs.
The mechanism of action involves inhibition of phosphodiesterase enzymes, resulting in increased levels of cyclic AMP, which helps reduce bronchial constriction. This leads to relief from symptoms such as wheezing, shortness of breath, chest tightness, and difficulty in breathing. The combination is particularly useful for long-term control and maintenance therapy in patients with chronic respiratory disorders.
Etophylline and Theophylline also improve respiratory function by enhancing diaphragmatic contractility and reducing airway resistance. Due to its effectiveness in providing sustained bronchodilation, it is commonly prescribed in both oral and injectable forms. This makes it a valuable therapeutic option for managing chronic respiratory conditions and improving overall breathing comfort.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing